Treatment of Benzodiazepine Overdose
The primary treatment for benzodiazepine overdose is supportive care with airway management, while flumazenil should be used selectively and cautiously due to its risk of precipitating seizures and withdrawal in specific patient populations.
Initial Management
- Establish and maintain an open airway as the first priority, providing bag-mask ventilation followed by endotracheal intubation when appropriate 1
- Address hypoxemia and hypercarbia promptly as these are the primary mechanisms of tissue injury and death in benzodiazepine overdose 1
- Contact a regional poison center (1-800-222-1222 in the United States) for expert guidance on management of specific poisoning cases 1
Supportive Care
- Provide standard airway management, support of breathing, and treatment of hypotension, dysrhythmias, or cardiac arrest according to local guidelines 1
- In cardiac arrest due to benzodiazepine overdose, follow standard BLS and ACLS algorithms as there are no specific antidotes indicated during cardiac arrest 1
- Consider activated charcoal administration for recent ingestions to reduce absorption 2
- Monitor vital signs, prevent aspiration, and implement measures to prevent deep vein thrombosis due to prolonged immobilization 2
Flumazenil Use
Indications
- Consider flumazenil for patients with known benzodiazepine overdose who have respiratory depression but are not in cardiac arrest 1
- Flumazenil may prevent the need for intubation and mechanical ventilation in carefully selected patients 1
- Can provide diagnostic value in cases of undifferentiated overdose or coma of unknown origin 3
Contraindications and Cautions
- Do not administer flumazenil to patients with undifferentiated coma due to risk of complications (Class III, LOE B) 1
- Avoid in patients with:
Dosing Protocol for Benzodiazepine Overdose
For management of suspected benzodiazepine overdose in adults 4:
- Initial dose: 0.2 mg IV over 30 seconds
- If desired level of consciousness is not achieved after 30 seconds, administer 0.3 mg IV over 30 seconds
- Further doses of 0.5 mg IV can be given over 30 seconds at 1-minute intervals
- Maximum cumulative dose: 3 mg (most patients respond to 1-3 mg)
- For non-responders after 5 mg total dose, consider alternative causes of sedation
For pediatric patients 1:
- Dose: 0.01-0.02 mg/kg IV (maximum: 0.2 mg per dose)
- May repeat at 1-minute intervals to maximum cumulative dose of 0.05 mg/kg or 1 mg, whichever is lower
Monitoring After Flumazenil Administration
- The duration of action of flumazenil (1-2 hours) is shorter than most benzodiazepines, requiring close monitoring for resedation 5, 3
- Observe patients continuously for at least 2 hours after the last dose of flumazenil 1
- For resedation, repeat doses may be given at 20-minute intervals as needed 4
- Consider continuous infusion (0.1-0.5 mg/hour) for patients requiring prolonged reversal 5
Special Considerations
- In mixed overdoses, benzodiazepine overdose should not preclude timely administration of naloxone when opioid overdose is also suspected 1
- Benzodiazepines and opioids together cause greater central nervous system and respiratory depression than either alone 1
- For patients on chronic benzodiazepines who develop toxicity, consider gradual tapering rather than abrupt reversal with flumazenil 1
Complications to Monitor
- Seizures (may respond to small doses of benzodiazepines) 5
- Cardiac arrhythmias including supraventricular tachycardia, ventricular dysrhythmias, and asystole 1
- Benzodiazepine withdrawal syndrome characterized by anxiety, agitation, and potentially life-threatening symptoms 5
- Increases in blood pressure and heart rate due to catecholamine release 5